aXichem announces indicative positive data from trail, regarding phenylcapcaisin’s effect on sports performance in athletes, carried out at University of Pablo Olavide, Spain
aXichem AB (publ) , a developer of natural analogue industrial compounds and a leading neutraceuticals ingredient provider, today announces first indicative positive results from a finalized trial including aXivite® . The trial’s aim was to determine the effect of phenylcapsaicin and to evaluate its effect on electrical muscle activity, biochemical responses, and neuromuscular performance. The trial was conducted in collaboration with aXichem’s partners LIFEPro Nutrition and Indiex Sport Nutrition